Professional Documents
Culture Documents
Hipertensi
Obesity
Decrease
Arterial
compliance
Endothelial
Dysfunction
Abnormal
Glucose
Metabolism
Abnormal lipid
Metabolism
Neurohormonal
Dysfunction
Accelerated
Atherogenesis
Renal-function
RenalChanges
LV Hypertrophy
And Dysfunction
Abnormal
Insulin
Metabolism
Blood-clotting
BloodMechanism
Change
Kannel WB. JAMA 1996, 275: 1571-1576; Weber MA et al. J Hum Hypertens 1991,
5: 417-423; Dzau VJ et al. J Cardiovasc Pharmacol 1993, 21 (Suppl 1): S1-S5
B
L
O
O
D
P
R
E
S
S
U
R
E
Short-term: HR and R
Daytime : degree of activity
Diurnal : BP fall during sleep
Seasonal : cold weather increases BP
Fisiologi
TD = cardiac output (co) x resistensi vascular (rv)
Patofisiologi hipertensi:
TD = cardiac output (co)
Regulation of BP:
Patogenesis hipertensi
Cardiac
output
meningkat
Resistensi
perifer
meningkat
Preload meningkat
Volume cairan meningkat krn asupan Na +++
atau retensi renal karena nefron atau GFR
Konstriksi Vena
Stimulasi RAAS berlebihan
Sistem saraf simpatis terlalu aktif
Konstriksi vaskular
Stimulasi RAAS berlebihan
Sistem saraf simpatis terlalu aktif
Perubahan genetik membran sel
Faktor karena endotel
Hipertropi vaskular
Stimulasi RAAS berlebihan
Sistem saraf simpatis terlalu aktif
Perubahan genetik membran sel
Faktor karena endotel
Hiperinsulinemia karena obesitas atau metabolik sindrom.
Etiologic Classification:
Primary/Essential Hypertension (95%)
Increased peripheral resistance (sympathetic tone)
stress, hormonal, neural.
Genetic, familial, life style.
Secondary Hypertension (5-10%)
Renal : GN, RAS, Renin tumors
Endocrine : Cushing, OCP, Thyrotoxicosis Myxdema,
Pheochromocytoma, Acromegaly.
Vascular: Coarctation of Aorta, PAN, Aortic
insufficiency.
Neurogenic: Psychogenic, Intracranial pressure,
olyneuritis etc.
Patogenesis hipertensi
1.
2.
3.
4.
5.
Renin-Angiotensin-Aldosterone
Plasma
volume
Detected by
&/Or
Kidney
(juxtaglomerular
apparatus)
Renin-Angiotensin-Aldosterone
vasoconstriction
PVR
Angiotensin II
thirst
[Na+]
Via ACE
(Angiotensin
Converting
Enzyme)
Releases
Renin
Converts
ADH
(anti-diuretic
(antihormone)
Angiotensin II
Angiotensin I
Angiotensinogen
Adrenal
cortex
Fluid
volume
Releases
Aldosterone
BP!
Na+
reabsorption
Angiotensin II
Sodium Retention
Blood Volume
Vasoconstriction
P. Resistance
Stimulasi simpatis
Stimulation of the sympathetic nervous system raises BP,
usually more in hypertensive or prehypertensive patients
than in normotensive patients.
Whether this hyperresponsiveness resides in the
sympathetic nervous system itself or in the myocardium
and vascular smooth muscle that it innervates is unknown,
but it can often be detected before sustained
hypertension develops.
A high resting pulse rate, which can be a manifestation of
increased sympathetic nervous activity
Hypertension
Defisiensi vasodilator
Deficiency of a vasodilator substance rather than excess of a
vasoconstrictor (eg, angiotensin, norepinephrine) may cause
hypertension.
The kallikrein system, which produces the potent vasodilator
bradykinin, is beginning to be studied.
Extracts of renal medulla contain vasodilators, including a neutral
lipid and a prostaglandin; absence of these
vasodilators
due to renal parenchymal disease or bilateral nephrectomy
would permit BP to rise.
Endothelial cells produce potent vasodilators (nitric oxide,
prostacyclin) and the most potent vasoconstrictor,
endothelin. Therefore, dysfunction of the endothelium could
have a profound effect on BP. The endothelium's role in
hypertension is being investigated.
Evidence that hypertensive persons have decreased activity of
nitric oxide is preliminary.
Changes in Preload
fluid volume<
preload<
( IMT: indeks massa tubuh, LFG: laju filtrasi glomerulus, PJK: penyakit jantung koroner)
contractility
(Starlings Law)<
blood pressure.
cardiac output.
Hyperplastic Arteriolosclerosis:
Necrotizing arteriolitis:
Thrombosis
Narrow Lumen
Fibrinoid Necrosis
Sistem kardiovaskular :
Left ventricular hypertrophy,
left atrial enlargement,
aortic root dilatation,
atrial and ventricular arrhythmias,
systolic and diastolic heart failure,
ischemic HD, dan
congestive heart failure.
Different Cardiac
Morphologies in Heart
Failure
(a) Normal;
(b) dilated
cardiomyopathy;
(c) hypertrophic
cardiomyopathy;
(d) diastolic
dysfunction.
Subarachnoid Haemorrhage:
Necrosis
Lacunar Infarct:
Retinopati hipertensi
Hemoraghi, eksudat, papil edem
Chronic hypertension
Arteriolosclerosis of deep
penetrating arterioles of
brain stem.
Single or multiple cavitary
infarcts lacunes.
Lenticular nucleus,
thalamus
Slit Haemorrhages.
Retinopati hipertensi
Hypertensive Retinopathy:
Grade I: Thickening of
arterioles.
Grade II: Focal Arteriolar
spasms. Vein constriction.
Grade III: Hemorrhages
(Flame shape), dot-blot and
Cotton wool (ischemia) and
hard waxy exudates (lipid
deposition).
Grade IV: Papilloedema
Renal disease
Hypertensive Retinopathy:
Arteriosclerosis cause the arteriole light
reflex to become broad and dull silver wire
Generalized or focal retinal arteriolar
constriction pale.
Superficial flame-shaped hemorrhages.
Small white foci of retinal ischemia (cottonwool spots).
Yellow hard exudates, due to lipid deposition
deep in the retina.
Benign
Nephrosclerosis
Polycystic Kidney
10
Renal Causes :
Leathery Granularity
Benign Nephrosclerosis
Kategori hipertensi
the Seventh Report of the Joint
National Committee of Prevention, Detection,
Evaluation, and Treatment of High Blood
Pressure (JNC VII), klasifikasi TD (mm Hg)
1. Rekomendasi
BP
Classification
Normal
Pre-hypertension
Stage 1
Hypertension
Stage 2
Hypertension
SBP
mmHg
DBP
mmHg
<120
and <80
120-139
140-159
or 80-89
or 90-99
160
or 100
11
Grade 1
Grade 2
Grade 3
140-159
160-179
>/= 180
90-99
100-109
>/= 110
MANIFESTASI
KLINIK
HIPERTENSI
HIPERTENSI
DIABETES
STROKE
Prognosis:
Sebagian besar individu yang terdiagnosis
hipertensi akan meningkat TDnya sebanding
dengan umur.
Hipertensi yang tidak diobati meningkatkan
risiko mortalitas sering disebut silent killer.
Hipertensi ringan sedang jika tidak diobati
dihubungkan dengan risiko atherosclerotic
disease pada 30% pasien dan organ damage
pada 50% pasien setelah hanya 8-10 tahun
onset.
12
HEREDITER--LINGKUNGAN
HEREDITER
Umur
Normotensi
Pra--hipertensi
Pra
0 - 30 tahun
Hipertensi dini
20 - 40 tahun
Hipertensi (klinis)
Tanpa komplikasi
Hipertensi
maligna
30 - 50 tahun
Dengan komplikasi
Otak
Ginjal
Iskemia
Sklerosis
Trombosis Gagal ginjal
Perdarahan
50% diagnosed
50% treated
I. Menentukan stratifikasi
13
Pengobatan Hipertensi
Pengobatan untuk menurunkan tekanan
darah akan menurunkan insiden stroke
3535-40%, infark miokard 20
20--25%, gagal
jantung 50%
Penelitian epidemiologis UKPDS
melaporkan setiap penurunan 10 mmHg
rerata tekanan darah sistolik
berhubungan dengan penurunan risiko 12%
untuk segala komplikasi dengan DM, 15%
untuk kematian dengan DM, 11% untuk
infark miokard & 13% untuk komplikasi
mikrovaskular
Penurunan BB
Mengurangi garam < 2.4 gr/day
Diet kuat K, Ca and Mg
Stop alkohol
Olah Raga teratur
Mengurangi/stop merokok
14